Synthesis of novel carbazole chalcones as radical scavenger, antimicrobial and cancer chemopreventive agents

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 3, 2013, Pages 593-600

  Bandgar, Babasaheb P ^a   Adsul, Laxman K ^a   Lonikar, Shrikant V ^a   Chavan, Hemant V ^a   Shringare, Sadanand N ^a   Patil, Sachin A ^a   Jalde, Shivkumar S ^a   Koti, Basawaraj A ^a   Dhole, Nagesh A ^b   Gacche, Rajesh N ^b   Shirfule, Amol ^c  

^a SOLAPUR UNIVERSITY   (India)

^b SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

^c NATIONAL INSTITUTE OF NUTRITION   (India)

Author keywords

Anticancer; Antimicrobial; Antioxidant; Carbazole; Chalcones; Lipinski rule

Indexed keywords

3 (9 METHYL 9H CARBAZOL 3 YL) 1 PHENYL PROPENONE; 3 FORMYL 9 METHYL CARBAZOLE; CARBAZOLE DERIVATIVE; CHALCONE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; DNA DAMAGE; DRUG SCREENING; DRUG SYNTHESIS; DRUG TOXICITY; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; ANTICARCINOGENIC AGENTS; ANTIFUNGAL AGENTS; ANTIOXIDANTS; CARBAZOLES; CELL LINE, TUMOR; CHALCONES; CHEMISTRY TECHNIQUES, SYNTHETIC; DRUG SCREENING ASSAYS, ANTITUMOR; FREE RADICAL SCAVENGERS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 84865471611     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.663365     Document Type: Article

References (45)

1. Aruoma O J, Halliwell B. Free Radicals and Food Additives (Eds) Talylor and Francis, London, 1991.
2. Halliwell B, Murcia MA, Chirico S, Aruoma OI. Free radicals and antioxidants in food and in vivo: What they do and how they work. Crit Rev Food Sci Nutr 1995;35:7-20.
3. Bursal E, Gülçin I. Polyphenol contents and in vitro antioxidant activities of lyophilised aqueous extract of kiwifruit (Actinidia deliciosa). Food Research International. 2011;44: 1482-1489
4. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
5. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release 2006;113:189-207.
6. Suzen S. Bioactive Heterocycles V, Chapter: "Antioxidant Activities of Synthetic Indole Derivatives and Possible Activity Mechanisms. Top Heterocycl Chem 2007;11:145-178.
7. Knölker HJ, Reddy KR. Isolation and synthesis of biologically active carbazole alkaloids. Chem Rev 2002;102:4303-4427.
8. Zhang FF, Gan LL, Zhou CH. Synthesis, antibacterial and antifungal activities of some carbazole derivatives. Bioorg Med Chem Lett 2010;20:1881-1884.
9. Asche C, Frank W, Albert A, Kucklaender U. Synthesis, antitumour activity and structure-activity relationships of 5H-benzo[b] carbazoles. Bioorg Med Chem 2005;13:819-837.
10. Long BH, Rose WC, Vyas DM, Matson JA, Forenza S. Discovery of antitumor indolocarbazoles: Rebeccamycin, NSC 655649, and fluoroindolocarbazoles. Curr Med Chem Anticancer Agents 2002;2:255-266.
11. Knolker H-J, Reddy KR. Chemistry and biology of carbazole alkaloids The alkaloids: Chemistry and Biology 2008;65:181-193.
12. Asche C, Demeunynck M.Antitumor carbazoles. Anticancer Agents Med Chem 2007;7:247-267.
13. Arbiser JL, Govindarajan B, Battle TE, Lynch R, Frank DA, Ushio-Fukai M et al. Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol 2006;126:1396-1402.
14. Fousteris MA, Papakyriakou A, Koutsourea A, Manioudaki M, Lampropoulou E, Papadimitriou E et al. Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulations. J Med Chem 2008;51:1048-1052.
15. Hu L, Li ZR, Li Y, Qu J, Ling YH, Jiang JD et al. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors. J Med Chem 2006;49:6273-6282.
16. Conchon E, Anizon F, Aboab B, Prudhomme M. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide. J Med Chem 2007;50:4669-4680.
17. Lampropoulou E, Manioudaki M, Fousteris M, Koutsourea A, Nikolaropoulos S, Papadimitriou E. Pyrrolo[2,3-a]carbazole derivatives as topoisomerase I inhibitors that affect viability of glioma and endothelial cells in vitro and angiogenesis in vivo. Biomed Pharmacother 2011;65:142-150.
18. Joseph B, Facompré M, Da Costa H, Routier S, Mérour JY, Colson P et al. Synthesis, cytotoxicity, DNA interaction and topoisomerase II inhibition properties of tetrahydropyrrolo[3,4-a]carbazole-1,3-dione and tetrahydropyrido-[3,2-b]pyrrolo[3,4-g]indole-1,3-dione derivatives. Bioorg Med Chem 2001;9:1533-1541.
19. Noguchi N, Nishino K, Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. Biochem Pharmacol 2000;59:1069-1076.
20. Zall A, Kieser D, Höttecke N, Naumann EC, Thomaszewski B, Schneider K et al. NSAID-derived ?-secretase modulation requires an acidic moiety on the carbazole scaffold. Bioorg Med Chem 2011;19:4903-4909.
21. Bandgar BP, Sarangdhar RJ, Viswakarma S, Ahamed FA. Synthesis and biological evaluation of orally active prodrugs of indomethacin. J Med Chem 2011;54:1191-1201.
22. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem 1999;6:1125-1149.
23. Go ML, Wu X, Liu XL. Chalcones: An update on cytotoxic and chemoprotective properties. Curr Med Chem 2005;12:481-499.
24. Gülçin I, Topal F, Cakmakci R, Bilsel M, Goren A C, Erdogan U. Pomological Features, Nutritional Quality, Polyphenol Content Analysis, and Antioxidant Properties of Domesticated and 3 Wild Ecotype Forms of Raspberries (Rubus idaeusL.). J Food Sci 2011;76:585-593.
25. Gülçin I. Antioxidant Activity of Eugenol: A StructureYActivity Relationship Study. J Medicinal Food 2011;14:975-985.
26. Halliwell B, Gutteridge J.M.C. Free radicals in biology and medicine, 3rd ed. Oxford university press. oxford, UK. 1999.
27. Kancheva VD, Saso L, Boranova PV, Khan A, Saroj MK, Pandey MK et al. Structure-activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: Correlation between experimental & theoretical data and synergistic effect. Biochimie 2010;92:1089-1100.
28. Kumar R, Ramachandran U, Srinivasan K, Ramarao P, Raichur S, Chakrabarti R. Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants. Bioorg Med Chem 2005;13:4279-4290.
29. Shi HP, Xu L, Cheng Y, He JY, Dai JX, Xing LW et al. Experimental and theoretical study of three new benzothiazole-fused carbazole derivatives. Spectrochim Acta A Mol Biomol Spectrosc 2011;81:730-738.
30. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-370.
31. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 2003;17:1195-1214.
32. Burrows CJ, Muller JG. Oxidative Nucleobase Modifications Leading to Strand Scission. Chem Rev 1998;98:1109-1152.
33. Rahman A, Fazal F, Greensill J, Ainley K, Parish JH, Hadi SM. Strand scission in DNA induced by dietary flavonoids: Role of Cu(I) and oxygen free radicals and biological consequences of scission. Mol Cell Biochem 1992;111:3-9.
34. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Med 1991;10:201-209.
35. Anto RJ, Sukumaran K, Kuttan G, Rao MN, Subbaraju V, Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett 1995;97:33-37.
36. van de Waterbeemd H, Gifford E. ADMET in silico modelling: Towards prediction paradise? Nat Rev Drug Discov 2003;2:192-204.
37. Lipinski C A, Lombardo F, Dominy B W, Feeney P J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 1997;23:3-25.
38. Hou T, Wang J, Zhang W, Xu X. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J Chem Inf Model 2007;47:460-463.
39. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-2623.
40. Navia M A, Chaturvedi P R. Design Principles for Orally. Bioavailable Drugs. Drug Discovery Today 1996;1:179-189.
41. Blois M S. Antioxidant Determinations by the Use of a Stable Free Radical. Nature. 1958;181:1199-1200.
42. Yu W, Zhao Y, Shu B. The radical scavenging activites of radix puerariae isoflavanoids: A chemiluminescence study. Food Chem 2004;86:525-529.
43. Wahab S I A, Abdul A B, Mohan S M, Al-Zubairi A S, Elhassan M M, Ibrahim M Y. Biological activities of Pereskia bleo extracts. Int J Pharmacol 2009;5:71-75.
44. Vadlapudi V, Bobbarala V, Penumajji S, Naidu K C. Excoecaria agallocha L. Antimicrobial Properties against Important Pathogenic Microorganisms. Int J Pharm Tech Res. 2009;4:865-867.
45. Miteva MA, Violas S, Montes M, Gomez D, Tuffery P, Villoutreix BO. FAF-Drugs: free ADME/tox filtering of compound collections. Nucleic Acids Res 2006;34:W738-W744.